Pulmonology

COVID-19   

Questions discussed in this category



How do you approach which risk to accept given that steroids have evidence for use in COVID-19 while is suggestion for harm in using steroids in influ...

Would you have a different opinion based on whether it is a new therapy or an existing and previously well-tolerated therapy for the patient?

Any differences in the risks between SBRT vs. conventionally fractionation? Concurrent immunotherapy? 

Should staging and treatment decisions be made based on imaging alone?


Papers discussed in this category


Adv Radiat Oncol, 2020 May 05

Cancer Discov, 2020 May 01

Lancet, 2020 May 28

Int. J. Radiat. Oncol. Biol. Phys., 2020 Apr 14

BMJ Open, 2019 May 05

Rheumatol Int, 2021 Jan 29

Eur Respir Rev, 2021 Dec 15

Ann Am Thorac Soc,

N Engl J Med, 2012 May 20